Immunization, Vaccines and Biologicals

20 May 2013

World Health Assembly opens to discuss major health issues

WHO's Health Assembly, the world's largest health policy-making body, opened its 66th Session on 20 May in Geneva with around 3000 participants from around the world. Major health issues to be discussed include protecting more children from vaccine-preventable diseases; intensifying efforts to eradicate polio; and monitoring of progress countries are making towards the Millennium Development Goals.

20 May 2013

Improving people’s health through immunization

D.Urfer

This year, the exhibits at the World Health Assembly reflect the Organization’s shift to the areas of work as defined in the 12th General Programme of Work, thus showing Member States that their vision is moving ahead under our programme of reform.

As such, vaccine-preventable diseases falls under WHO’s priority area of work in Category 1: communicable diseases which includes HIV/AIDS, Malaria, Neglected Tropical Diseases and Tuberculosis.

17 May 2013

Yellow fever vaccination booster not needed

Women queuing with their vaccination cards in Africa
WHO/C. Banluta

The yellow fever ‘booster’ vaccination given ten years after the initial vaccination is not necessary, according to the World Health Organization. An article published in WHO’s Weekly Epidemiological Record reveals that the Organization’s Strategic Advisory Group of Experts on immunization (SAGE) has reviewed the latest evidence and concluded that a single dose of vaccination is sufficient to confer life-long immunity against yellow fever disease.

15 May 2013

Thirty-one priority countries eliminated maternal and neonatal tetanus

P.Blanc

Tetanus, one of the most deadly diseases a mother and her newborn can face, has been eliminated in over half of 59 priority countries, the Maternal and Neonatal Tetanus Elimination Initiative partners announced today.

The countries are: Bangladesh, Benin, Burkina Faso, Burundi, Cameroon, China, Comoros, Congo, Cote d' Ivoire, Egypt, Eritrea, Ghana, Guinea-Bissau, Iraq, Liberia, Malawi, Mozambique, Myanmar, Namibia, Nepal, Rwanda, Senegal, South Africa, Tanzania, Timor Leste, Togo, Turkey, Uganda, Viet Nam, Zambia and Zimbabwe.


Our areas of work

Quality and standards

Ensuring adherence of vaccines, other biological products and immunization equipment to international norms and standards

Financing

Immunization financing analyses, country profiles, indicators and tools

Supply and procurement

Developing procedures to ensure efficient supply and procurement of vaccines and immunization equipment to countries

Service delivery and accelerated disease control

Developing immunization systems and policies to ensure availability of vaccines to everyone in need of them.

Research and development

Supporting and facilitating the development, clincial evaluation and access to safe, effective and affordable vaccines

Safety

Providing global policies and best practices for vaccine and immunization safety

Surveillance, assessment and monitoring

Monitoring and assessing the impact of strategies and activities for reducing morbidity and mortality as a result of vaccine-preventable diseases

New and under-utilized vaccines

Decision-making and key issues surrounding the use and introduction of new vaccines